Erythropoietin-producing hepatocellular carcinoma A2 (EphA2), a member of the EPH family of receptor tyrosine kinases, is widely expressed in various cancers and plays a pivotal role in tumor development and progression (11). Here, EPHA2 is linked to neoplasm.